Criticism of the Fourth Law on the amendment of the German Pharmaceuticals Act
The presentation of the outlined objections against the Fourth Law is based on a critical acclaim of jurist Scarlett Jansen. They critically acclaimed the previous draft bill of the Fourth Law:
Jansen, Scarlett (2016): Der Schutz der Patienten und Probanden bei klinischen Prüfungen nach den geplanten Neuerungen im Arzneimittelrecht. In: Medizinrecht 34(6), 417-423. (German)